1. Home
  2. AGX vs STOK Comparison

AGX vs STOK Comparison

Compare AGX & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$328.05

Market Cap

4.7B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.01

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
STOK
Founded
1961
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
AGX
STOK
Price
$328.05
$32.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$321.00
$33.11
AVG Volume (30 Days)
414.2K
910.0K
Earning Date
12-04-2025
11-04-2025
Dividend Yield
0.61%
N/A
EPS Growth
76.74
N/A
EPS
8.49
0.68
Revenue
$915,030,000.00
$205,632,000.00
Revenue This Year
$11.43
$430.24
Revenue Next Year
$18.27
N/A
P/E Ratio
$38.64
$46.98
Revenue Growth
13.49
1128.17
52 Week Low
$101.02
$5.35
52 Week High
$399.30
$38.69

Technical Indicators

Market Signals
Indicator
AGX
STOK
Relative Strength Index (RSI) 49.44 53.64
Support Level $290.10 $31.50
Resistance Level $343.95 $33.90
Average True Range (ATR) 19.06 2.25
MACD -1.05 -0.15
Stochastic Oscillator 76.81 38.02

Price Performance

Historical Comparison
AGX
STOK

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: